Translate

Τετάρτη 25 Νοεμβρίου 2020

Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.

o.lakala70 shared this article with you from Inoreader
CONCLUSION: Erlotinib-associated GT was identified in 15% patients with NSCLC. Fluid-filled colon and segmental involvement were the most common imaging manifestations. PMID: 32892106 [PubMed - indexed for MEDLINE] (Source: Clinical Lung Cancer)
View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate